TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection (2019)
Fonte: Journal of clinical investigation insight. Unidade: ICB
Assuntos: IMUNOLOGIA, PARASITOLOGIA, LEISHMANIA, MACRÓFAGOS, FAGOCITOSE, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAUTER, Ismael Pretto et al. TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection. Journal of clinical investigation insight, v. 4, n. 10, p. 1-17, 2019Tradução . . Disponível em: https://doi.org/10.1172/jci.insight.126207. Acesso em: 03 nov. 2024.APA
Sauter, I. P., Sotomayor, K. G. M., Assis, J. B. de, Nunes, A. de S., Torrecilhas, A. C. T., Staquicini, D. I., et al. (2019). TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection. Journal of clinical investigation insight, 4( 10), 1-17. doi:10.1172/jci.insight.126207NLM
Sauter IP, Sotomayor KGM, Assis JB de, Nunes A de S, Torrecilhas ACT, Staquicini DI, Pasqualini R, Arap W, Cortez M. TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection [Internet]. Journal of clinical investigation insight. 2019 ; 4( 10): 1-17.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1172/jci.insight.126207Vancouver
Sauter IP, Sotomayor KGM, Assis JB de, Nunes A de S, Torrecilhas ACT, Staquicini DI, Pasqualini R, Arap W, Cortez M. TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection [Internet]. Journal of clinical investigation insight. 2019 ; 4( 10): 1-17.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1172/jci.insight.126207